Skip to content

Erich Bluhmki

Boehringer Ingelheim (Germany)

2 papers in the Anchorcite directory, published between 2008 and 2015, cited 19,434 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Bernard Zinman · 1 paper
  • Christoph Wanner · 1 paper
  • John M. Lachin · 1 paper
  • DAVID H. FITCHETT · 1 paper
  • Stefan Hantel · 1 paper
  • Michaela Mattheus · 1 paper
  • Theresa Devins · 1 paper
  • Odd Erik Johansen · 1 paper

Papers

  1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine · 2015 · 12,596 citations

    BACKGROUND: The effects of empagliflozin, an inhibitor of sodium-glucose cotransporter 2, in addition to standard care, on cardiovascular morbidity and mortality in patients with type 2 diabetes at high cardiovascular risk are not known. METHODS: We randomly assigned patients to…

  2. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeNew England Journal of Medicine · 2008 · 6,838 citations

    BACKGROUND: Intravenous thrombolysis with alteplase is the only approved treatment for acute ischemic stroke, but its efficacy and safety when administered more than 3 hours after the onset of symptoms have not been established. We tested the efficacy and safety…

Metadata from OpenAlex (CC0).